Brief: IX Biopharma Posts QTRLY Loss S$3.6 MLN
11/02/2019 13:12
Feb 11 (Reuters) - IX Biopharma Ltd IXBI.SI :
* QTRLY LOSS FOR FINANCIAL PERIOD S$3.6 MILLION VERSUS LOSS
OF
S$3.2 MILLION
* QTRLY REVENUE S$1.5 MILLION VERSUS S$1.8 MILLION
Source text for Eikon: ID:nSNZ32ShQl
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture